Shield Therapeutics (STX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

1.53p
   
  • Change Today:
    -0.050p
  • 52 Week High: 12.50
  • 52 Week Low: 1.50
  • Currency: UK Pounds
  • Shares Issued: 782.06m
  • Volume: 5,511,671
  • Market Cap: 11.93m

STX Overview

Shield is a de-risked commercial stage, pharmaceutical company focused on addressing iron deficiency in adults with or without anaemia. Our clear purpose is to develop products that help patients become people again, enabling them to enjoy the things that make a difference in their everyday lives.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -904.7% -166.7%
ROCE 5574.3%  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 2.7 0.8
Pr/Book 2.2  
Latest F'cast
Revenue 194.1% 221.8%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

STX Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-18 11.88 (5.15) (1.89)p n/a n/a n/a n/a 0.0%
31-Dec-19 0.72 (9.07) (7.55)p n/a n/a n/a n/a 0.0%
31-Dec-20 10.39 (1.89) (1.89)p n/a n/a n/a n/a 0.0%
31-Dec-21 1.52 (19.91) (10.00)p n/a n/a n/a n/a 0.0%
31-Dec-22 4.47 (40.08) (17.00)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

STX Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-23 14.37 (23.96) (5.04)p n/a n/a n/a n/a 0.0%
31-Dec-24 54.09 (10.33) (1.51)p n/a n/a n/a n/a 0.0%
31-Dec-25 107.42 16.04 1.46p 1.0 n/a n/a n/a 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Latest STX Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

STX Market Data

Currency UK Pounds
Share Price 1.53p
Change Today -0.050p
% Change -3.17 %
52 Week High 12.50
52 Week Low 1.50
Volume 5,511,671
Shares Issued 782.06m
Market Cap 11.93m

STX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
41.42% below the market average41.42% below the market average41.42% below the market average41.42% below the market average41.42% below the market average
50.94% above the sector average50.94% above the sector average50.94% above the sector average50.94% above the sector average50.94% above the sector average
Price Trend
96.79% below the market average96.79% below the market average96.79% below the market average96.79% below the market average96.79% below the market average
92.98% below the sector average92.98% below the sector average92.98% below the sector average92.98% below the sector average92.98% below the sector average
Income Not Available
Growth
57.12% above the market average57.12% above the market average57.12% above the market average57.12% above the market average57.12% above the market average
78.38% above the sector average78.38% above the sector average78.38% above the sector average78.38% above the sector average78.38% above the sector average

What The Brokers Say

Strong Buy 0
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 1
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

STX Dividends

No dividends found

Trades for 12-Apr-2024

Time Volume / Share Price
16:42 1,000,000 @ 1.50p
16:29 240,772 @ 1.53p
16:25 15 @ 1.50p
16:16 322 @ 1.55p
16:15 50,000 @ 1.51p

Top of Page